Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 30, 2013 - Issue 8
Submit an article Journal homepage
320
Views
19
CrossRef citations to date
0
Altmetric
Research Article

A Prospective Study of Tubular Dysfunction in Pediatric Patients with Beta Thalassemia Major Receiving Deferasirox

Majid NaderiAli Ebn-e Abitaleb Hospital, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, IranCorrespondence[email protected]
,
Simin Sadeghi-BojdAli Ebn-e Abitaleb Hospital, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
,
Ali Kord ValeshabadDivision of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, MD, USA
,
Alireza JahantighAli Ebn-e Abitaleb Hospital, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
,
Shaban AlizadehHematology Department, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
,
Akbar Dorgalaleh
,
Shadi TabibianHematology Department, Allied Medical School, Tehran University of Medical Sciences, Tehran, Iran
&
Taregh BamediAli Ebn-e Abitaleb Hospital, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
 show all
Pages 748-754 | Received 22 Feb 2013, Accepted 05 Jul 2013, Published online: 17 Oct 2013

REFERENCES

  • Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353(11):1135–1146.
  • Musallam KM, Taher AT. Mechanisms of renal disease in beta-thalassemia. J Am Soc Nephrol: JASN. 2012;23(8):302–1299.
  • Cianciulli P, Sollecito D, Sorrentino F, Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy. Kidney Int. 1994;46(2):467–470.
  • Sumboonnanonda A, Malasit P, Tanphaichitr VS, Renal tubular function in beta-thalassemia. Pediatr Nephrol. 1998;12(4):280–283.
  • Mohkam M, Shamsian BS, Gharib A, Early markers of renal dysfunction in patients with beta-thalassemia major. Pediatr Nephrol. 2008;23(6):971–976.
  • Brosnahan G, Gokden N, Swaminathan S. Acute interstitial nephritis due to deferasirox: a case report. Nephrol Dial Transplant. 2008;23(10):3356–3358.
  • Lopez-Novoa JM, Quiros Y, Vicente L, New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int. 2011;79(1):33–45.
  • Enas H, Nagla EM. Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Ital J Pediatr. 2010;36–39.
  • Aldudak B, Karabay Bayazit A, Noyan A, Renal function in pediatric patients with beta-thalassemia major. Pediatr Nephrol. 2000;15(1–2):109–112.
  • Volti SLI, Gregorio FDI, Schiliro G. Acute changes in renal function associated with deferoxamine therapy. Arch Pediatr Adolesc Med. 1990;144(10):1069–1070.
  • Economou M, Printza N, Teli A, Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox. Acta Haematol. 2010;123(3):148–152.
  • Smolkin V, Halevy R, Levin C, Renal function in children with beta-thalassemia major and thalassemia intermedia. Pediatr Nephrol. 2008;23(10):1847–1851.
  • Portman R, Kissane J, Robson A. Use of beta 2 microglobulin to diagnose tubulo-interstitial renal lesions in children. Kidney Int. 1986;30(1):91–98.
  • Guder W, Hofmann W. Markers for the diagnosis and monitoring of renal tubular lesions. Clin Nephrol. 1992;38:S3–S7.
  • Herrero-Morín JD, Málaga S, Fernández N, Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children. Crit Care. 2007;11(3):R59.
  • Rheault MN, Bechtel H, Neglia JP, Kashtan CE. Reversible Fanconi syndrome in a pediatric patient on deferasirox. Pediatr Blood Cancer. 2011;56(4):674–676.
  • Rafat C, Fakhouri F, Ribeil JA, Fanconi syndrome due to deferasirox. Am J Kidney Dis. 2009;54(5):931–934.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.